Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Cadila Healthcare trades in green on the bourses

14-Jan2019

Cadila Healthcare trades in green on the bourses

Cadila Healthcare is currently trading at Rs. 351.20, up by 2.00 points or 0.57% from its previous closing of Rs. 349.20 on the BSE.

The scrip opened at Rs. 352.00 and has touched a high and low of Rs. 353.40 and Rs. 349.70 respectively.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 450.95 on 15-Jan-2018 and a 52 week low of Rs. 330.65 on 26-Oct-2018.

Last one week high and low of the scrip stood at Rs. 353.40 and Rs. 344.30 respectively. The current market cap of the company is Rs. 35749.09 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 17.34% and 7.87% respectively.

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Betamethasone Dipropionate Cream USP (US RLD - DIPROLENE AF), 0.05%. It will be manufactured at the group's Topical manufacturing facility at Ahmedabad. This medication is a strong corticosteroid and is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Betamethasone reduces the swelling, itching and redness that can occur in these types of conditions.

The group also received a final approval for Amlodipine and Atorvastatin Tablets USP (US RLD - Caduet) in the strengths of 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10mg/80 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad. This combination product contains two active ingredients - amlodipine and atorvastatin. Amlodipine reduces blood pressure and the workload on the heart by relaxing the walls of the blood vessels. It is used to lower blood pressure and to treat angina (chest pain). Atorvastatin is used in combination with diet and exercise to treat high cholesterol. It works by blocking an enzyme that is needed to make cholesterol in the body.

The group now has 245 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


Related News

View all news

SpiceJet jumps on reporting passenger load factor of 94% in February

Spicejet is currently trading at Rs. 99.05, up by 7.40 points or 8.07% from its previous closing of Rs. 91.65 on the BSE.The scrip opened at Rs. 93.50 and has touched a high and low of Rs. 104.70 and Rs.......

Tata Power trades higher on the BSE

Tata Power Company is currently trading at Rs. 73.25, up by 1.25 points or 1.74% from its previous closing of Rs. 72.00 on the BSE.The scrip opened at Rs. 72.05 and has touched a high and low of Rs. 73.75......

InterGlobe Aviation soars on reporting passenger load factor of 88.4% in February

Interglobe Aviation is currently trading at Rs. 1438.90, up by 16.10 points or 1.13% from its previous closing of Rs. 1422.80 on the BSE.The scrip opened at Rs. 1409.00 and has touched a high and low of......

Top News

View all news

Infosys to enter into agreement with The House Fund II

Infosys is going to enter into an agreement with The House Fund II, L.P., an AI-focused fund targeting startups from the University of California - Berkeley, committing to invest $10.0 million.......

EID Parry receives approval for investment Rs 70 crore in PSRIPL

EID Parry (INDIA) has received approval for investment upto Rs 70 crore in the equity share capital of Parry Sugars Refinery India (PSRIPL), a wholly owned subsidiary of the Company. The Board of directors......

SBI raises Rs 1,251 crore by issuing Basel III-compliant bonds

State Bank of India (SBI) has raised Rs 1,251.30 crore by issuing Basel III-compliant bonds. The Committee of Directors for Capital Raising at its meeting held on 22 March 2019 deliberated and accorded......